These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26074740)

  • 21. [Cathinones use in Paris].
    Batisse A; Grégoire M; Marillier M; Fortias M; Djezzar S
    Encephale; 2016 Aug; 42(4):354-60. PubMed ID: 26847479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Growing Problem of New Psychoactive Substances (NPS).
    Madras BK
    Curr Top Behav Neurosci; 2017; 32():1-18. PubMed ID: 27571747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics.
    Calinski DM; Kisor DF; Sprague JE
    Psychopharmacology (Berl); 2019 Mar; 236(3):881-890. PubMed ID: 30069588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.
    Palamar JJ; Salomone A; Vincenti M; Cleland CM
    Drug Alcohol Depend; 2016 Apr; 161():200-5. PubMed ID: 26883685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic cathinones (bath salts): legal status and patterns of abuse.
    Fass JA; Fass AD; Garcia AS
    Ann Pharmacother; 2012 Mar; 46(3):436-41. PubMed ID: 22388331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current "legal highs".
    Johnson LA; Johnson RL; Portier RB
    J Emerg Med; 2013 Jun; 44(6):1108-15. PubMed ID: 23528960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications.
    White CM
    J Clin Pharmacol; 2016 Nov; 56(11):1319-1325. PubMed ID: 27029951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic cathinones: "a khat and mouse game".
    Katz DP; Bhattacharya D; Bhattacharya S; Deruiter J; Clark CR; Suppiramaniam V; Dhanasekaran M
    Toxicol Lett; 2014 Sep; 229(2):349-56. PubMed ID: 24973490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine.
    Muskiewicz DE; Resendiz-Gutierrez F; Issa O; Hall FS
    Pharmacol Biochem Behav; 2020 Apr; 191():172871. PubMed ID: 32061662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic cathinone adulteration of illegal drugs.
    Oliver CF; Palamar JJ; Salomone A; Simmons SJ; Philogene-Khalid HL; Stokes-McCloskey N; Rawls SM
    Psychopharmacology (Berl); 2019 Mar; 236(3):869-879. PubMed ID: 30338489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of synthetic cathinones emerging in recent years (2019-2022).
    Kuropka P; Zawadzki M; Szpot P
    Forensic Toxicol; 2023; 41(1):25-46. PubMed ID: 36124107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of synthetic substances in France and in Europe].
    Debruyne D; Monzon E; Perino J; Haramburu F; Daveluy A; Lazès-Charmetant A; Giraudon I
    Therapie; 2021; 76(3):221-228. PubMed ID: 32859404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.
    Glennon RA
    Adv Pharmacol; 2014; 69():581-620. PubMed ID: 24484988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic cathinones ("bath salts").
    Banks ML; Worst TJ; Rusyniak DE; Sprague JE
    J Emerg Med; 2014 May; 46(5):632-42. PubMed ID: 24565885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic cathinones related fatalities: an update.
    Zaami S; Giorgetti R; Pichini S; Pantano F; Marinelli E; Busardò FP
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):268-274. PubMed ID: 29364498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
    Sande M
    Int J Drug Policy; 2016 Jan; 27():65-73. PubMed ID: 25908121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pharmacokinetic profile of synthetic cathinones in a pregnancy model.
    Strange LG; Kochelek K; Keasling R; Brown SD; Pond BB
    Neurotoxicol Teratol; 2017 Sep; 63():9-13. PubMed ID: 28811141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.